Last Round
M&A
Aug 28, 2017
Est. Valuation
$145.81M
Total Funding Raised
$102.87M
Company Overview
Merna Therapeutics is a biotechnology company focused on the development of RNA-based therapies and polypeptide-based treatments for oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
biotechnologydrug discoveryRNA therapeuticsbiopharmaoncologygene editingpolypeptide drugsbiotech R&DRNA medicinetargeted therapytherapeutic candidatesdrug pipelinepre-clinical researchsortilin receptorsbiotech licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Merna Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Merna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 28, 2017 | ||||
| IPO Announced | Oct 1, 2015 | ||||
| Series D | Apr 30, 2015 | ||||
| Grant | May 21, 2014 | ||||
| Series C | Oct 24, 2012 | ||||
Series B | Aug 23, 2011 |
Merna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baxter Ventures | Series D |
| Morningside Ventures | Series D |
| Osage University Partners | Series C, Series D |
| Santé Ventures | Series D |
| National Institutes of Health (NIH) | Grant |
| Rock Springs Capital | Series D |
| Correlation Ventures | Series C, Series D |
Merna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Merna Therapeutics's valuation, stock price, and market status.